Three Months Ended
|
||||||||
January 28,
2024
|
January 29,
2023
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
39,082
|
$
|
28,950
|
||||
Adjustments to reconcile net income to net cash
|
||||||||
provided by operating activities:
|
||||||||
Depreciation and amortization
|
20,702
|
19,105
|
||||||
Share-based compensation
|
2,573
|
1,821
|
||||||
Changes in operating assets, liabilities and other
|
(20,849
|
)
|
(22,196
|
)
|
||||
Net cash provided by operating activities
|
41,508
|
27,680
|
||||||
Cash flows from investing activities:
|
||||||||
Purchases of property, plant and equipment
|
(43,314
|
)
|
(31,097
|
)
|
||||
Purchases of available-for-sale debt securities
|
(2,436
|
)
|
-
|
|||||
Proceeds from maturities of available-for-sale debt securities
|
2,500
|
-
|
||||||
Government incentives
|
1,091
|
1,014
|
||||||
Other
|
(56
|
)
|
(87
|
)
|
||||
Net cash used in investing activities
|
(42,215
|
)
|
(30,170
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Repayments of debt
|
(1,194
|
)
|
(9,218
|
)
|
||||
Proceeds from share-based arrangements
|
936
|
672
|
||||||
Net settlements of restricted stock awards
|
(2,613
|
)
|
(1,168
|
)
|
||||
Net cash used in financing activities
|
(2,871
|
)
|
(9,714
|
)
|
||||
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
|
13,026
|
27,499
|
||||||
Net increase in cash, cash equivalents, and restricted cash
|
9,448
|
15,295
|
||||||
Cash, cash equivalents, and restricted cash, beginning of period
|
501,867
|
322,409
|
||||||
Cash, cash equivalents, and restricted cash, end of period
|
$
|
511,315
|
$
|
337,704
|